title: [Neuroborreliosis--a disease with many faces].
abstract: Borreliosis has been widely recognized in Switzerland and is often used in unclear cases with non-specific symptoms. Two illustrative cases should emphasize the current options for diagnosis and therapy of neuroborreliosis. The keystones of the diagnostic instruments are a history with typical symptoms and analysis of the cerebrospinal fluid with determination of appropriate antibodies. Therapy deals with ceftriaxon with intravenous and doxycyclin with oral application making ambulatory treatment possible.
authors.affiliation: Muskelzentrum/ALS Clinic, Kantonsspital St. Gallen. david.czell@gmx.ch
authors.forename: D
authors.initials: D
authors.lastname: Czell
authors.forename: B
authors.initials: B
authors.lastname: Rodic
authors.forename: R
authors.initials: R
authors.lastname: Imoberdorf
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D025065:Borrelia burgdorferi / Q000276:immunology; D002443:Ceftriaxone / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004318:Doxycycline / Q000627:therapeutic use; D005158:Facial Paralysis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007262:Infusions, Intravenous; D020852:Lyme Neuroborreliosis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D011129:Polyradiculoneuropathy / Q000188:drug therapy / Q000209:etiology*; D011128:Polyradiculopathy / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D002443:Ceftriaxone; D004318:Doxycycline